Development code · Small Molecule
ANC501
ANC501 is a development code for Brezivaptan (TS-121 / ANC-501), developed by Taisho Pharmaceutical Co., Ltd..
- Status
- Discontinued for Major depressive disorder
- Mechanism
- V1B receptor Antagonist
- Developer
- Taisho Pharmaceutical Co., Ltd.
Programs
- Brezivaptan (TS-121 / ANC-501) for Major depressive disorderDiscontinuedDiscontinued
Also known as
- TS-121
- ANC-501
- THY-1773
- TS121
- THY1773
- brezivaptan
- 1370444-22-6
- 2-[3-(3-chlorophenyl)-1-{4-[2-(morpholin-4-yl)ethyl]phenyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-N-(propan-2-yl)acetamide